- SAVAB-Flanders vzw
- Sint Truidersteenweg 193
- 3700 Tongeren
- info@savab.be
- BTW BE 0434.366.196
Hier kan je een overzicht vinden van de momenteel in Europa lopende oncologische klinische studies.
| Country | Requested tumour types for clinical trial | Type of trial |
|---|---|---|
| Belgium | Thyroid tumour |
Evaluation of diagnostic marker Optimization metabolic radiotherapy |
| Head and neck tumour | Fluorescence-guided surgery | |
| Osteosarcoma, chondrosarcoma, benign osteolytic lesions | Percutaneous cementoplasty | |
| France |
Anal sac adenocarcinoma Thyroid tumour Nasal tumour Head and neck tumour Transitional cell carcinoma - bladder Chemodectoma Pheochromocytoma Gastro-intestinal stromal tumour |
Undisclosed |
| Hepatocellular carcinoma | Tumour nodule ablation during surgery | |
| Glioma | Oral medicinal treatment | |
| Solid tumours | Immunotherapy | |
| Spain | Mammary carcinoma | Use of metronomic chlorambucil, firocoxib and/or their combination as adjuvant therapy |
| Oral melanoma | Evaluation of a compound's therapeutic affects against metastatic disease not amenable to surgery | |
| Sweden | Mammary carcinoma | Use of metronomic chlorambucil, firocoxib and/or their combination as adjuvant therapy |
| Switzerland | Nasal tumour | radiotherapy |
| Brain tumour | radiotherapy | |
| Cutaneous mast cell tumours | Lymphography and lymphoscinthigraphy for sentinel node mapping and resection | |
| Soft tissue sarcoma | Fluorescence-guided surgery | |
| United Kingdom | All tumour types | Aspartame for the prevention of chemotherapy-induced diarrhoea |
| All tumour types | Quility of life study | |
| Mammary carcinoma | Use of metronomic chlorambucil, firocoxib and/or their combination as adjuvant therapy |